SYNBIOTIC SE

News

16.12.2025 11:49:53
EQS-News: Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
18.11.2025 10:41:24
EQS-News: SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
21.10.2025 10:03:44
EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate
20.10.2025 09:00:14
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
02.10.2025 13:26:43
EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
14.08.2025 11:19:43
EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
29.07.2025 12:54:04
EQS-News: Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
11.06.2025 11:48:45
EQS-News: Successful roadshow continues: SYNBIOTIC keeps expanding its presence in the cannabis and hemp industry
23.04.2025 09:24:43
EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Lending (free of charge) of 50,000 shares as part of a securities lending programme.
17.04.2025 14:14:23
EQS-News: IRIS Capital invests in SYNBIOTIC's growth strategy

Downloads

Latest Research
Initiation

Latest Research

Christian Sandherr

20 Oct 25

Temporary headwinds from regulatory uncertainty; chg. est.

Update
Christian Sandherr

18 Dec 24

The new group continues to take shape; chg. est.

Update
Christian Sandherr

17 Sep 24

SynBiotic transformation: Reaching new operational high(t)s

Initiation
Christian Sandherr

29 Aug 23

Gearing up to capitalize on favorable market dynamics; chg.

Update
Christian Sandherr

28 Dec 22

Strategic realignment to capitalize on cannabis legalization; chg.

Update

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.